Rifaximin, a topical antibiotic, appeared to be as effective as the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in managing irritable bowel syndrome ...

Rifaximin (Xifaxan) is approved for the treatment of adults with irritable bowel syndrome plus diarrhea and has demonstrated efficacy versus placebo for the improvement of abdominal and bowel symptoms ...

The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s involvement in litigation. The FDA's tentative approval of rifaximin 550 mg ...

Researchers analyzed the efficacy of rifaximin for relieving IBS-D symptoms, specifically abdominal pain, bloating, and bowel movement urgency. A 2-week course of rifaximin significantly improved ...

Rifaximin (Xifaxan) is approved for the treatment of adults with irritable bowel syndrome plus diarrhea (IBS-D) and has demonstrated efficacy versus placebo for the improvement of abdominal and bowel ...

Most Medicare Part D prescription drug plans and Medicare Advantage plans with drug coverage include rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic ...

Xifaxan is prescribed to treat traveler’s diarrhea caused by specific strains of E. coli, irritable bowel syndrome with diarrhea (IBS-D), and to prevent recurring episodes of hepatic encephalopathy.

Xifaxan (rifaximin) is a brand-name drug prescribed for irritable bowel syndrome with diarrhea (IBS-D), traveler’s diarrhea, and hepatic encephalopathy (HE). The drug’s dosage varies depending on a ...